{"abstract":"The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/10/27/2022-23378.html","cfr_references":[],"citation":"87 FR 65081","comment_url":null,"comments_close_on":"2022-11-28","correction_of":null,"corrections":[],"dates":"Submit written comments (including recommendations) on the collection of information by November 28, 2022.","disposition_notes":null,"docket_ids":["Docket No. FDA-2017-D-0085"],"dockets":[{"supporting_documents":[{"title":"Reference-30-GRAS Notices Search Results Common Use In Food - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance","document_id":"FDA-2017-D-0085-0048"},{"title":"Reference-28-Pew-2013-Draft-COI-Guidance-Consideration-FDA re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0028"},{"title":"Reference-27-NCCN-2014-NCCN-Disclosure-Policies-Potential-Conflicts-Interest re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0027"},{"title":"Reference-26-Guyatt-2010-Vexing-problem-guidelines-conflicts-interest-potential-solution re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0026"},{"title":"Reference-25-Norris-2011-Conflict-interest-clinical-practice-guideline-development-systematic-review re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0025"},{"title":"Reference-24-Alpert-2004-ACCF-AHA-Codes-Conduct-Human-Studies-Research re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0024"},{"title":"Reference-23-About-FEMA-GRAS-Program re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0023"},{"title":"Reference-21-FDA-2014-Guidance-Public-Availability-Advisory-Committee-Members-Financial-Interest-Information-Waivers re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0022"},{"title":"Reference-20-FDA-2016-Draft-Guidance-Procedures-Evaluating-Appearance-Issues-FDA-Advisory-Committees re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0021"},{"title":"Reference-18- Mancuso-2014-Effects-cognitive-biases-distributed-team-decision-making re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0019"}],"agency_name":"FDA","documents":[{"comment_count":1,"comment_start_date":"2022-10-27","updated_at":"2023-02-27T20:05:33.668-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2017-D-0085-0042","allow_late_comments":null,"id":"FDA-2017-D-0085-0042","comment_end_date":"2022-11-29","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":31,"id":"FDA-2017-D-0085","title":"Best Practices for Convening a GRAS Panel: Draft Guidance for Industry; Availability"}],"document_number":"2022-23378","effective_on":null,"end_page":65085,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/10/27/2022-23378.xml","html_url":"https://www.federalregister.gov/documents/2022/10/27/2022-23378/agency-information-collection-activities-submission-for-office-of-management-and-budget-review","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-23378?publication_date=2022-10-27","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-10-27/2022-23378/mods.xml","not_received_for_publication":null,"page_length":5,"page_views":{"count":696,"last_updated":"2026-06-13 20:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-10-27/pdf/2022-23378.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-23378.pdf?1666788319","publication_date":"2022-10-27","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/10/27/2022-23378.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Reference-30-GRAS Notices Search Results Common Use In Food - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance","document_id":"FDA-2017-D-0085-0048"},{"title":"Reference-28-Pew-2013-Draft-COI-Guidance-Consideration-FDA re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0028"},{"title":"Reference-27-NCCN-2014-NCCN-Disclosure-Policies-Potential-Conflicts-Interest re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0027"},{"title":"Reference-26-Guyatt-2010-Vexing-problem-guidelines-conflicts-interest-potential-solution re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0026"},{"title":"Reference-25-Norris-2011-Conflict-interest-clinical-practice-guideline-development-systematic-review re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0025"},{"title":"Reference-24-Alpert-2004-ACCF-AHA-Codes-Conduct-Human-Studies-Research re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0024"},{"title":"Reference-23-About-FEMA-GRAS-Program re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0023"},{"title":"Reference-21-FDA-2014-Guidance-Public-Availability-Advisory-Committee-Members-Financial-Interest-Information-Waivers re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0022"},{"title":"Reference-20-FDA-2016-Draft-Guidance-Procedures-Evaluating-Appearance-Issues-FDA-Advisory-Committees re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0021"},{"title":"Reference-18- Mancuso-2014-Effects-cognitive-biases-distributed-team-decision-making re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance","document_id":"FDA-2017-D-0085-0019"}],"comments_count":1,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2017-D-0085","supporting_documents_count":31,"docket_id":"FDA-2017-D-0085","document_id":"FDA-2017-D-0085-0042","regulation_id_number":null,"title":"Best Practices for Convening a GRAS Panel: Draft Guidance for Industry; Availability","checked_regulationsdotgov_at":"2023-02-28T01:05:32Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":65081,"subtype":null,"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Generally Recognized as Safe: Best Practices for Convening a Generally Recognized as Safe Panel","toc_doc":"Substances Generally Recognized as Safe: Best Practices for Convening a Generally Recognized as Safe Panel","toc_subject":"Agency Information Collection Activities; Proposals, Submissions, and Approvals:\n","topics":[],"type":"Notice","volume":87}